Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-000751-15Phase 3Active
Phase 3, randomised, double-blind trial in diabetes mellitus type 1 (T1D) comparing Calcitriol with Placebo (2 arms). Primary endpoints: Glycometabolic control and Endogenous insulin secretion. Started Jul 2005; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-000751-15.